AAAAAA

   
Results: 1-21 |
Results: 21
MODIFICATION OF TUMOR BLOOD-FLOW - CURRENT STATUS AND FUTURE-DIRECTIONS
Authors: CHAPLIN DJ HILL SA BELL KM TOZER GM
Citation: Dj. Chaplin et al., MODIFICATION OF TUMOR BLOOD-FLOW - CURRENT STATUS AND FUTURE-DIRECTIONS, Seminars in radiation oncology, 8(3), 1998, pp. 151-163
SPATIAL RESPONSE OF THE HSN RAT-TUMOR TO THE ENDOTHELIN-B (ETB) RECEPTOR AGONIST IRL-1620 - COMPARISON TO ETB RECEPTOR DISTRIBUTION
Authors: BELL KM TOZER GM POOLE BA PRISE VE CHAPLIN DJ
Citation: Km. Bell et al., SPATIAL RESPONSE OF THE HSN RAT-TUMOR TO THE ENDOTHELIN-B (ETB) RECEPTOR AGONIST IRL-1620 - COMPARISON TO ETB RECEPTOR DISTRIBUTION, Journal of vascular research, 35, 1998, pp. 293-293
THE COMPARATIVE EFFECTS OF THE NOS INHIBITOR, N-OMEGA-NITRO-L-ARGININE, AND THE HAEMOXYGENASE INHIBITOR, ZINC PROTOPORPHYRIN-IX, ON TUMOR BLOOD-FLOW
Authors: TOZER GM PRISE VE MOTTERLINI R POOLE BA WILSON J CHAPLIN DJ
Citation: Gm. Tozer et al., THE COMPARATIVE EFFECTS OF THE NOS INHIBITOR, N-OMEGA-NITRO-L-ARGININE, AND THE HAEMOXYGENASE INHIBITOR, ZINC PROTOPORPHYRIN-IX, ON TUMOR BLOOD-FLOW, International journal of radiation oncology, biology, physics, 42(4), 1998, pp. 849-853
TUMOR VASCULAR-RESPONSE TO THE ENDOTHELIN-B RECEPTOR AGONIST IRL1620 - SPATIAL-DISTRIBUTION OF BLOOD-FLOW MODIFICATION
Authors: BELL KM TOZER GM POOLE BA PRISE VE CHAPLIN DJ
Citation: Km. Bell et al., TUMOR VASCULAR-RESPONSE TO THE ENDOTHELIN-B RECEPTOR AGONIST IRL1620 - SPATIAL-DISTRIBUTION OF BLOOD-FLOW MODIFICATION, British Journal of Cancer, 78, 1998, pp. 95-95
COMBRETASTATIN A-4-P AS A TUMOR VASCULAR TARGETING AGENT
Authors: TOZER GM PRISE VE WILSON J VOJNOVIC B SHAN SQ DEWHIRST MW CHAPLIN DJ
Citation: Gm. Tozer et al., COMBRETASTATIN A-4-P AS A TUMOR VASCULAR TARGETING AGENT, British Journal of Cancer, 78, 1998, pp. 96-96
VASCULAR-RESPONSE OF TUMOR AND NORMAL-TISSUES TO ENDOTHELIN-1 FOLLOWING ANTAGONISM OF ETA AND ETB RECEPTORS IN ANESTHETIZED RATS
Authors: BELL KM PRISE VE CHAPLIN DJ WORDSWORTH S TOZER GM
Citation: Km. Bell et al., VASCULAR-RESPONSE OF TUMOR AND NORMAL-TISSUES TO ENDOTHELIN-1 FOLLOWING ANTAGONISM OF ETA AND ETB RECEPTORS IN ANESTHETIZED RATS, International journal of cancer, 73(2), 1997, pp. 283-289
INHIBITION OF NITRIC-OXIDE SYNTHASE INDUCES A SELECTIVE REDUCTION IN TUMOR BLOOD-FLOW THAT IS REVERSIBLE WITH L-ARGININE
Authors: TOZER GM PRISE VE CHAPLIN DJ
Citation: Gm. Tozer et al., INHIBITION OF NITRIC-OXIDE SYNTHASE INDUCES A SELECTIVE REDUCTION IN TUMOR BLOOD-FLOW THAT IS REVERSIBLE WITH L-ARGININE, Cancer research, 57(5), 1997, pp. 948-955
COMBRETASTATIN A-4, AN AGENT THAT DISPLAYS POTENT AND SELECTIVE TOXICITY TOWARD TUMOR VASCULATURE
Authors: DARK GG HILL SA PRISE VE TOZER GM PETTIT GR CHAPLIN DJ
Citation: Gg. Dark et al., COMBRETASTATIN A-4, AN AGENT THAT DISPLAYS POTENT AND SELECTIVE TOXICITY TOWARD TUMOR VASCULATURE, Cancer research, 57(10), 1997, pp. 1829-1834
UNTITLED
Authors: TOZER GM CUNNINGHAM VJ
Citation: Gm. Tozer et Vj. Cunningham, UNTITLED, Microvascular research, 51(3), 1996, pp. 400-402
A COMPARATIVE-STUDY OF TUMOR BLOOD-FLOW MODIFICATION IN 2 RAT-TUMOR SYSTEMS USING ENDOTHELIN-1 AND ANGIOTENSIN-II - INFLUENCE OF TUMOR SIZEON ANGIOTENSIN-II RESPONSE
Authors: BELL KM PRISE VE SHAFFI KM CHAPLIN DJ TOZER GM
Citation: Km. Bell et al., A COMPARATIVE-STUDY OF TUMOR BLOOD-FLOW MODIFICATION IN 2 RAT-TUMOR SYSTEMS USING ENDOTHELIN-1 AND ANGIOTENSIN-II - INFLUENCE OF TUMOR SIZEON ANGIOTENSIN-II RESPONSE, International journal of cancer, 67(5), 1996, pp. 730-738
SPATIAL HETEROGENEITY OF TUMOR BLOOD-FLOW MODIFICATION INDUCED BY ANGIOTENSIN-II - RELATIONSHIP TO RECEPTOR DISTRIBUTION
Authors: TOZER GM SHAFFI KM PRISE VE BELL KM
Citation: Gm. Tozer et al., SPATIAL HETEROGENEITY OF TUMOR BLOOD-FLOW MODIFICATION INDUCED BY ANGIOTENSIN-II - RELATIONSHIP TO RECEPTOR DISTRIBUTION, International journal of cancer, 65(5), 1996, pp. 658-663
TUMOR BLOOD-FLOW MODIFICATION BY ENDOTHELIN-RELATED PEPTIDES IN THE RAT HSN FIBROSARCOMA
Authors: BELL KM PRISE VE CHAPLIN DJ TOZER GM
Citation: Km. Bell et al., TUMOR BLOOD-FLOW MODIFICATION BY ENDOTHELIN-RELATED PEPTIDES IN THE RAT HSN FIBROSARCOMA, British Journal of Cancer, 74, 1996, pp. 161-163
REDUCED CAPACITY OF TUMOR BLOOD-VESSELS TO PRODUCE ENDOTHELIUM-DERIVED RELAXING FACTOR - SIGNIFICANCE FOR BLOOD-FLOW MODIFICATION
Authors: TOZER GM PRISE VE BELL KM DENNIS MF STRATFORD MRL CHAPLIN DJ
Citation: Gm. Tozer et al., REDUCED CAPACITY OF TUMOR BLOOD-VESSELS TO PRODUCE ENDOTHELIUM-DERIVED RELAXING FACTOR - SIGNIFICANCE FOR BLOOD-FLOW MODIFICATION, British Journal of Cancer, 74(12), 1996, pp. 1955-1960
NITRIC-OXIDE IN BIOLOGICAL-FLUIDS - ANALYSIS OF NITRITE AND NITRATE BY HIGH-PERFORMANCE ION CHROMATOGRAPHY
Authors: EVERETT SA DENNIS MF TOZER GM PRISE VE WARDMAN P STRATFORD MRL
Citation: Sa. Everett et al., NITRIC-OXIDE IN BIOLOGICAL-FLUIDS - ANALYSIS OF NITRITE AND NITRATE BY HIGH-PERFORMANCE ION CHROMATOGRAPHY, Journal of chromatography, 706(1-2), 1995, pp. 437-442
THE INFLUENCE OF NITRIC-OXIDE ON TUMOR VASCULAR TONE
Authors: TOZER GM PRISE VE BELL KM
Citation: Gm. Tozer et al., THE INFLUENCE OF NITRIC-OXIDE ON TUMOR VASCULAR TONE, Acta oncologica, 34(3), 1995, pp. 373-377
THE MODIFICATION OF BLOOD-FLOW IN TUMORS AND THEIR SUPPLYING ARTERIESBY NICOTINAMIDE
Authors: HIRST DG KENNOVIN GD TOZER GM PRISE VE FLITNEY EW
Citation: Dg. Hirst et al., THE MODIFICATION OF BLOOD-FLOW IN TUMORS AND THEIR SUPPLYING ARTERIESBY NICOTINAMIDE, Acta oncologica, 34(3), 1995, pp. 397-400
EFFECT OF ENDOTHELIN-1 AND SARAFOTOXIN S6C ON BLOOD-FLOW IN A RAT-TUMOR
Authors: BELL KM PRISE VE CHAPLIN DJ TOZER GM
Citation: Km. Bell et al., EFFECT OF ENDOTHELIN-1 AND SARAFOTOXIN S6C ON BLOOD-FLOW IN A RAT-TUMOR, Journal of cardiovascular pharmacology, 26, 1995, pp. 222-225
THE RESPONSE OF TUMOR VASCULATURE TO ANGIOTENSIN-II REVEALED BY ITS SYSTEMIC AND LOCAL-ADMINISTRATION TO TISSUE-ISOLATED TUMORS
Authors: TOZER GM SHAFFI KM
Citation: Gm. Tozer et Km. Shaffi, THE RESPONSE OF TUMOR VASCULATURE TO ANGIOTENSIN-II REVEALED BY ITS SYSTEMIC AND LOCAL-ADMINISTRATION TO TISSUE-ISOLATED TUMORS, British Journal of Cancer, 72(3), 1995, pp. 595-600
CHARACTERIZATION OF TUMOR BLOOD-FLOW USING A TISSUE-ISOLATED PREPARATION
Authors: TOZER GM SHAFFI KM PRISE VE CUNNINGHAM VJ
Citation: Gm. Tozer et al., CHARACTERIZATION OF TUMOR BLOOD-FLOW USING A TISSUE-ISOLATED PREPARATION, British Journal of Cancer, 70(6), 1994, pp. 1040-1046
RESISTANCE TO FLOW-THROUGH TISSUE-ISOLATED TRANSPLANTED RAT-TUMORS LOCATED IN 2 DIFFERENT SITES
Authors: SENSKY PL PRISE VE TOZER GM SHAFFI KM HIRST DG
Citation: Pl. Sensky et al., RESISTANCE TO FLOW-THROUGH TISSUE-ISOLATED TRANSPLANTED RAT-TUMORS LOCATED IN 2 DIFFERENT SITES, British Journal of Cancer, 67(6), 1993, pp. 1337-1341
MODIFICATION OF TUMOR BLOOD-FLOW USING THE HYPERTENSIVE AGENT, ANGIOTENSIN-II
Authors: TOZER GM SHAFFI KM
Citation: Gm. Tozer et Km. Shaffi, MODIFICATION OF TUMOR BLOOD-FLOW USING THE HYPERTENSIVE AGENT, ANGIOTENSIN-II, British Journal of Cancer, 67(5), 1993, pp. 981-988
Risultati: 1-21 |